Tissue factor: From 'just one of the coagulation factors' to a major player in physiology

Blood Coagulation and Fibrinolysis

Volumn 15, Issue SUPPL. 1, 2004, Pages

  Spek, C Arnold ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Coagulation; Development; Endotoxaemia; Inflammation; Intracellular signalling; Metastasis; Mice; Tissue factor; Tumour

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 10A INHIBITOR; ENDOTOXIN; PROTEINASE ACTIVATED RECEPTOR 2; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTICOAGULATION; APOPTOSIS; CELL ADHESION; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FIBRINOGEN SYNTHESIS; GENE INACTIVATION; INCUBATION TIME; LETHALITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; THROMBOGENESIS;

ANIMALS; EMBRYONIC DEVELOPMENT; HEMOSTASIS; HUMANS; INFLAMMATION; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; THROMBOPLASTIN;

EID: 2942587360     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200405001-00002     Document Type: Conference Paper

References (56)

1. Buchanan A. On the coagulation of the blood and other fibriniferous liquids. London Med Gazette 1845; 2:1844-1848.
2. Bāchli E. History of tissue factor. Br J Haematol 2000; 110:248-255.
3. Howell WH. Theories of blood coagulation. Physiol Rev 1935; 15:435-470.
4. Chargraff E, Bendich A, Cohen SS. The thromboplastic protein: structure, properties, disintegration. J Biochem 1994; 156:161-178.
5. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting, Science 1964; 145:1310-1312.
6. MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202:498-499.
7. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74:5260-5264.
8. Bach R, Nemerson Y, Konigsberg W. Purification and characterization of bovine tissue factor. J Biol Chem 1981; 256:8324-8331.
9. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988; 23:339-368.
10. Roberts HR, Monroe DM, Oliver JA, Chang JV, Hoffman M. Newer concepts of blood coagulation. Haemophilia 1998; 4:331-334.
11. Veldman A, Hoffman M, Ehrenforth S. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa. Curr Med Chem 2003; 10:797-811.
12. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003; 17(suppl):S1-S5.
13. Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis 1995; 6(suppl):S7-S13.
14. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumour cells in mice. J Clin Invest 1994; 94:1320-1327.
15. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest 2003; 124:58S-68S.
16. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69:247-254.
17. Koomagi R, Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 1998; 79:19-22.
18. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2:209-215.
19. Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, et al. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000; 31:443-447.
20. Ohta S, Wada H, Nakazaki T, Maeda Y, Nobori T, Shiku H, et al. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Anticancer Res 2002; 22:2991-2996.
21. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92:8205-8209.
22. Vrana JA, Stang MT, Grande JP, Getz MJ. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 1996; 56:5063-5070.
23. Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 1998; 101:1372-1378.
24. Seto S, Onodera H, Kaido T, Yoshikawa A, Ishigami S, Arii S, et al. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 2000; 88:295-301.
25. Amirkhosravi A, Meyer T, Chang JY, Amaya M, Siddiqui F, Desai H, et al. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 2002; 87:930-936.
26. Hembrough TA, Swartz GM, Papathanassiu A, Vlasuk GP, Rote WE, Green SJ, et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumour growth through a nonhemostatic mechanism. J Cancer Res 2003; 63:2997-3000.
27. Versteeg HH, Bresser HL, Spek CA, Richel DJ, Van Deventer SJH, Peppelenbosch MP. Regulation of the P21Ras-MAP kinase pathway by factor VIIa. J Thromb Haemost 2003; 1:1012-1018.
28. Versteeg HH, Peppelenbosch M, Spek CA. Tissue factor signal transduction in angiogenesis. Carcinogenesis 2003; 24:1009-1013.
29. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induce to synthesize tissue factor. J Biol Chem 1995; 270:4650-4660.
30. Camerer E, Rottingen JA, Iversen JG, Prydza H. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 1996; 271:29034-29042.
31. Peppelenbosch MP, Versteeg HH. Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med 2001; 11:335-339.
32. Versteeg HH, Hoedemaeker I, Diks SH, Stam JC, Spaargaren M, van Bergen EN, et al. Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac. J Biol Chem 2000; 275:28750-28756.
33. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998; 10:202-207.
34. Versteeg HH, Evertzen MW, van Deventer SJ, Peppelenbosch MP. The role of phosphatidylinositolide-3-kinase in basal mitogen-activated protein kinase activity and cell survival. FEBS Lett 2000; 465:69-73.
35. Funa K, Uramoto H. Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor. Acta Biochim Pol 2003; 50:647-658.
36. McCarthy JB, Skubitz AP, Iida J, Mooradian DL, Wilke MS, Furcht LT. Tumour cell adhesive mechanisms and their relationship to metastasis. Semin Cancer Biol 1991; 2:155-167.
37. Danen EH, Sonnenberg A. Integrins in regulation of tissue development and function. J Pathol 2003; 200:471-480.
38. Versteeg HH, Spek CA, van Deventer SJ, Richel DJ, Peppelenbosch MP. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene 2004; 23:410-417.
39. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997; 278:294-298.
40. Sorensen BB, Rao VM, Tornehave D, Gammeltoft S, Petersen LC. Antiapoptotic effect of coagulation factor VIIa. Blood 2003; 102:1708-1715.
41. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci 1996; 93:6258-6263.
42. Carmeliet P, Mackman N, Moons TL, Gressens P, Vlaenderen IV, Demunck H, et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383:73-75.
43. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88:1583-1587.
44. Parry GCN, Erlich JH, Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998; 101:560-569.
45. Pawlinski R, Fernandes A, Kehrle B, Pedersen B, Parry G, Erlich J, et al. Tissue factor deficiency causes cardiac fibcosis and left ventricular dysfunction. Proc Natl Acad Sci USA 2002; 99:15333-15338.
46. Dackiw A, McGilvray ID, Woodside M, Nathens AB, Marshall JC, Rotstein OD. Prevention of endotoxin-induced mortality by antitissue factor immunization. Arch Surg 1996; 131:1273-1279.
47. Enkhbaatar P, Okajima K, Uchiba M, Isobe H, Okabe H. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide. Thromb Haemost 2001; 86:1573-1577.
48. Moons AH, Peters RJ, Cate H, Bauer KA, Vlasuk GP, Buller HR, et al. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. Thromb Haemost 2002; 88:627-631.
49. Pawlinski R, Pedersen B, Schabbauer G, Tencati M, Holscher T, Boisvert W, et al. Role of tissue factor and protease activated receptors in a mouse model of endotoxemia. Blood 2004; 103:1342-1347.
50. Taylor FB Jr. Role of tissue factor and factor VIIa in the coagulant and inflammatory response to LD100 Escherichia coli in the baboon. Haemostasis 1996; 26(suppl):83-91.
51. Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998; 79:495-499.
52. Todoroki H, Nakamura S, Higure A, Okamoto K, Takeda S, Nagata N, et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery 2000; 127:209-216.
53. Schoenmakers SHH, Groot AP, Florquin S, Reitsma PH, Spek CA. Blood cell-derived tissue factor influences host response during murine endotoxemia. Blood Cells Mol Dis 2004; 32:325-333.
54. Cunningham MA, Romas P, Hutchinson P, Holdsworth S, Tipping PG. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999; 94:3413-3420.
55. Weijer S, Schoenmakers SHH, Florquin S, Levi M, Vlasuk GP, Rote WE, et al. Inhibition of the tissue factor-factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis 2004; in press.
56. Vlasuk GP, Bradbury A, Lopez-Kinninger L, Colon S, Bergum PW, Maki S, et al. Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X. Thromb Haemost 2003; 90:803-812.